Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...
Thermo Fisher executives explain why they bypassed Massachusetts in the search for the firm's second U.S. collaboration ...
More than 74,000 participants in clinical trials lost their access to care as a result of Trump administration cuts, ...
Alzheimer's disease (AD) is a devastating cause of memory loss and cognitive decline, for which no curative treatment is available.
Cincinnati Children's dedicated a new research center in Sharonville to finding treatments for patients with cancer, blood ...
Alzheimer's disease (AD) is a devastating cause of memory loss and cognitive decline, for which no curative treatment is ...
At the Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs ...
The Fellenz family was in court Monday, with Children's Wisconsin, to determine if they had a valid case. "It was dismissed because the judge placed the brain as an organ, and his ruling on organs is ...
Community Health System and Valley Children’s Healthcare are leading the charge in Central Valley cancer treatment, bringing advanced cellular and gene therapies — including CAR-T therapy — closer to ...
In this week’s Focus on Health, Dr. Robin Miller shares encouraging research showing that a new gene therapy slowed disease ...
AZoLifeSciences on MSN
CRISPR Gene Editing Reverses Chemotherapy Resistance in Lung Cancer
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results